Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses. | Front Pharmacol | 2026 | 41756243 | PubTator, text mining | PubMed |
| Molecular Mechanisms, Dynamic Lesions, and Therapeutic Targets in Intestinal Ischemia-Reperfusion Injury: A Systematic Review. | Int J Mol Sci | 2026 | 41751903 | PubTator, text mining | PubMed |
| Preclinical exploration and current clinical applications of immunotherapeutic strategies for hepatocellular carcinoma. | Front Immunol | 2026 | 41743701 | PubTator, text mining | PubMed |
| Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance. | Cancer Pathog Ther | 2026 | 41732210 | PubTator, text mining | PubMed |
| Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis. | Front Immunol | 2026 | 41727450 | PubTator, text mining | PubMed |
| A Machine Learning-Guided Approach for Identifying Potential HCAR1 Antagonists in Lactate-Driven Cancers. | ACS Omega | 2026 | 41726659 | PubTator, text mining | PubMed |
| Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements and computational modeling. | J Mol Cell Cardiol Plus | 2026 | 41716202 | PubTator, text mining | PubMed |
| A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. | ACS Chem Neurosci | 2026 | 41704197 | PubTator, text mining | PubMed |
| Exploring the basis of Traditional Chinese Medicine in treating cardiovascular disease: insights into the microbiota-gut-heart axis. | Chin Med | 2026 | 41634734 | PubTator, text mining | PubMed |
| Impaired adrenergic regulation of Kv channels underlies LC hyperactivity and early-onset sleep disruption in AD-like amyloidogenic mice. | Alzheimers Dement | 2026 | 41611634 | PubTator, text mining | PubMed |
| Efficacy of prolotherapy in temporomandibular joint disorders with hypertonic dextrose and Polydeoxyribonucleotide (PDRN). | J Oral Facial Pain Headache | 2026 | 41607324 | PubTator, text mining | PubMed |
| The purinergic signaling interfaces in breast cancer angiogenesis. | Purinergic Signal | 2026 | 41575692 | PubTator, text mining | PubMed |
| Rapid and Label-Free Structural Proteomics Using One-Step Swift Trypsin LiP-MS. | ACS Omega | 2026 | 41552556 | PubTator, text mining | PubMed |
| Polydeoxyribonucleotide (PDRN) in Dentistry: Narrative Review for Mechanisms and Emerging Clinical Applications. | Tissue Eng Regen Med | 2026 | 41546790 | PubTator, text mining | PubMed |
| <p>Converting 'cold' to 'hot' hepatocellular carcinoma for improved immunotherapy (Review)</p>. | Mol Med Rep | 2026 | 41543193 | PubTator, text mining | PubMed |
| BindFlow: A Free, User-Friendly Pipeline for Absolute Binding Free Energy Calculations Using Free Energy Perturbation or MM(PB/GB)SA. | J Chem Theory Comput | 2026 | 41498855 | PubTator, text mining | PubMed |
| Structure-activity relationship analysis of 5'-substituted C2-hexynyl-4'-thioadenosine analogs as dual A2A/A3 adenosine receptor agonists with tunable selectivity and anti-inflammatory activity. | Eur J Med Chem | 2026 | 41273796 | PubTator, text mining | PubMed |
| Overexpression of adenosine receptor (A1, A2a, A2b, A3) genes in esophageal tumor tissue: A2b adenosine receptor as a potential biomarker and anticancer target. | J Appl Genet | 2026 | 40504303 | PubTator, text mining | PubMed |
| Purinergic signaling and cholangiocyte regeneration: a new frontier in ischemic liver injury. | Front Transplant | 2025 | 41626144 | PubTator, text mining | PubMed |
| Perineural invasion as a neuro-immune niche in head and neck cancer: mechanisms of immune evasion and therapeutic implications. | Front Immunol | 2025 | 41445745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=2